Is sell-side coverage objective?

Hi, I'm on the VC side with little exposure to public markets or equity research. Heard a public markets investor tell me they aggregate coverage from different sell-side analysts and use that to give them direction.

Question for those of you in equity research:

1. How objective is your coverage? (my understanding coverage exists for marketing and not a critical analysis)

2. How do you decide on which companies to cover? (is this purely driven by front-office requirements, or is there an overarching strategy to have sufficient coverage within a given market?)

9 Comments
 
Most Helpful

1) ER is all marketing at the end of the day with some objective analysis sprinkled in here and there.

2) Coverage is based on a few things, but I think its mostly about (a) buy side interest and (b) just covering the biggest names in your sector. The whole point is to get client interaction, so covering some small cap company no one cares about doesn’t benefit SS much.

 

Correct. Equity Research isn't meant to be a stock-pick (despite the "recommendations" component). It's a tool used to generate business for other lines of the company...i.e. does it help get an IB mandate if you can market the stock post IPO and generate liquidity, do you have access to the management team so a hedge fund is willing to trade through your brokerage to get access, etc. If there's no interest in the name, there's no reason to cover it. 

 

Ignore my title I work in ER at a boutique. The commenters above refer to ER at BBs, which isn't respective of the entire industry. ER reports at BBs are largely rubbish and for market SS ER at boutiques think ISI (before EVR acquisition), TPH (before PWP acquisition), Cowen (Before TD), Berenberg, Wolfe, etc. actually publish quality research that people that invest in the public market actually read and take seriously.

Personally, I'd never take SS ER seriously. Just recently, an ER analyst at a BB that had a sell rating on a company magically changed his rating right as the IBD announced that they were working with that same company. I wonder why

 

Depends on the type of firm. Excluding the reputable boutiques who monetize only on client subscriptions, 

1. How objective is your coverage? Not objective at all

2. How do you decide on which companies to cover? Combination of what the analyst wants to cover, what the firm pressures them to cover for revenue purposes (they gonna rate them "SELL" right? Sike), and what they must cover as a result of being on the IPO

 

I think it depends heavily on your analyst. I’d like to think that my team does a fair amount of fundamental research.

My lead analyst has had very successful careers as an entrepreneur and on the buy side. As a result, he is in his seat rn purely bc he loves it — he doesn’t care about appeasing corporates or driving banking revenues. Obviously we soften language, but I can say that 100% of the content we have published in the ~18 months I’ve been here has been solely our view.

As for the companies we cover; our “core” coverage is the companies that clients are most interested in. When we pick up coverage it’s either 1. Banking is driving it 2. Clients are asking us abt it…deal flow has been slow so it’s been mostly the second one since I started working.

 

Mollitia quod quo amet distinctio. Porro sunt autem veritatis eveniet et ut. Ut consectetur et sed repellendus et qui.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (78) $151
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”